arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Ingevity Corp

NGVT
$77.81 ▲ +0.62 (+0.80%) at close
Materials ·Chemicals & Allied Products ·USChemicals & Allied Products
48 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
58
Health
Fair
Neutral
auto_awesome

Analytical Summary

Ingevity Corp shows mixed fundamentals. On the positive side, Operating Margin (%) remains strong. Consider comparing against peers in the Materials sector before making investment decisions.

Market Cap $2.7B
Dividend Yield
Revenue Growth -14.0%
Op. Margin None
ROIC None
FCF / Share $-0.40
Trailing P/E 76.3x
Price / Book 57.2x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

48-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$314.10M
↓ -14.0%
Net Income Profit after all expenses
$59.80M
↑ +191.7%
Operating Margin Operating profit as % of sales
52.2%
↑ +78.6% 91th
FCF / Share Free cash flow per share
$-0.40
↓ -601.3%
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
65
Financial Health
74
Cash Quality
7

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 13 years · 48 quarters